A Phase 4 Trial to Describe the Immunogenicity, Safety, and Tolerability of MenB-fHbp in Participants > 10 Years of Age With Asplenia or Complement Deficiency

• Authors: HOMOLA Lukáš; KORBAL Piotr; THOMSEN Isaac; WANG Elizabeth; LIU Yanping; MURTHY Ashlesh; O'NEILL Robert; MAGUIRE Jason D; MOUGHAN Beth; PEYRANI Paula; ANDERSON Annaliesa S; BEESLAAR Johannes
• Year of publication: 2026
• Type: Peer-reviewed scientific article
• Magazine / Source: American Journal of Hematology
• MU Faculty or unit: Faculty of Medicine
• web: https://onlinelibrary.wiley.com/doi/10.1002/ajh.70261